Published in Obesity and Diabetes Week, January 30th, 2006
An experienced consulting company, Environ will assist Spherix with protocol development and selection of contract research organizations (CROs) to run the trial. It will also monitor performance and data. Upon successful completion of the trial, Environ will assess the results and help Spherix prepare a new drug application (NDA) for submittal to the U.S. Food and Drug Administration (FDA). Spherix has ordered 7 metric tons of Naturlose from the firm's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.